Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 136 to 150 of 588 results for pregnancy

  1. Contraception (QS129)

    This quality standard covers contraception for women, including emergency contraception. It describes high-quality care in priority areas for improvement.

  2. What are the roles of insulin pump therapy (continuous subcutaneous insulin infusion) and continuous glucose monitoring in helping women with diabetes to achieve blood glucose targets before pregnancy?

    in helping women with diabetes to achieve blood glucose targets before pregnancy? Any explanatory notes(if applicable) Babies born to...

  3. Management of severe nausea and vomiting: What is the clinical and cost effectiveness of corticosteroids for women with severe nausea and vomiting in pregnancy?

    effectiveness of corticosteroids for women with severe nausea and vomiting in pregnancy? Any explanatory notes(if applicable) For a...

  4. Physical health of people in prison (NG57)

    This guideline covers assessing, diagnosing and managing physical health problems of people in prison. It aims to improve health and wellbeing in the prison population by promoting more coordinated care and more effective approaches to prescribing, dispensing and supervising medicines.

  5. Spotlight on valproate prescribing

    not be used by any woman or girl able to have children unless there is a pregnancy prevention programme (PPP) in place. Valproate is...

  6. Jaundice in newborn babies under 28 days (CG98)

    This guideline covers diagnosing and treating jaundice, which is caused by increased levels of bilirubin in the blood, in newborn babies (neonates). It aims to help detect or prevent very high levels of bilirubin, which can be harmful if not treated.

  7. Vamorolone for treating Duchenne muscular dystrophy [ID4024]: draft guidance

    We are listening to your views on this Technology appraisal guidance. Comments close 24 April 2024.

  8. Relugolix–estradiol–norethisterone acetate for treating pain associated with endometriosis [ID3982]: draft guidance

    We are listening to your views on this Technology appraisal guidance. Comments close 22 April 2024.

  9. Idebenone for treating visual impairment in Leber's hereditary optic neuropathy in people 12 years and over [ID547]: draft guidance

    We are listening to your views on this Technology appraisal guidance. Comments close 16 May 2024.

  10. Selpercatinib for advanced thyroid cancer with RET alterations that has not been treated with systemic therapy [ID6132]: draft guidance

    We are listening to your views on this Technology appraisal guidance. Comments close 23 May 2024.

  11. Efanesoctocog alfa for treating and preventing bleeding episodes in haemophilia A [ID6170]: draft guidance

    We are listening to your views on this Technology appraisal guidance. Comments close 10 June 2024.

  12. Natural Cycles for monitoring fertility (MIB244)

    NICE has developed a medtech innovation briefing (MIB) on Natural Cycles for monitoring fertility .

  13. Colorectal cancer . Patient decision aid on Lynch syndrome: should I take aspirin to reduce my chance of getting bowel cancer?

    is no good evidence that aspirin causes harm to the baby in early pregnancy when taken at lower doses, or at higher doses taken short...

  14. Chronic heart failure in adults: diagnosis and management (NG106)

    This guideline covers diagnosing and managing chronic heart failure in people aged 18 and over. It aims to improve diagnosis and treatment to increase the length and quality of life for people with heart failure.

  15. Patient safety

    Our guidelines make evidence based, best practice recommendations. These help to improve patient safety and reduce the risk of harm across the health system.